Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 6:12 pm Purchase |
2024-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
Van Herk Investments B.V. | 11,461,995 10.900% |
3,291,741 (+40.29%) |
Filing History |
| 2025-02-12 09:46 am Purchase |
2024-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
Adage Capital Management L.P. | 9,602,280 9.300% |
9,602,280 (New Position) |
Filing History |
| 2024-02-14 06:08 am Purchase |
2024-02-09 | 13G | ProQR Therapeutics N.V. PRQR |
Van Herk Investments B.V. | 8,170,254 10.100% |
1,024,035 (+14.33%) |
Filing History |
| 2024-02-09 06:37 am Purchase |
2023-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
Van Herk Investments B.V. | 7,146,219 8.800% |
2,865,354 (+66.93%) |
Filing History |
| 2023-09-14 5:20 pm Purchase |
2023-09-11 | 13G | ProQR Therapeutics N.V. PRQR |
Van Herk Investments B.V. | 4,280,865 5.300% |
4,280,865 (New Position) |
Filing History |
| 2023-02-14 10:13 am Sale |
2022-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
RTW Investments, LP | 0 0.000% |
-7,027,725 (Position Closed) |
Filing History |
| 2023-02-09 5:00 pm Purchase |
2022-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
Stichting Aescap Life Sciences | 5,406,159 7.600% |
578,787 (+11.99%) |
Filing History |
| 2023-02-09 12:31 pm Sale |
2023-02-09 | 13G | ProQR Therapeutics N.V. PRQR |
FMR CORP | 0 0.000% |
-4,462,438 (Position Closed) |
Filing History |
| 2023-02-09 11:50 am Sale |
2022-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
ADAGE CAPITAL PARTNERS GP LLC | 3,628,467 4.490% |
-1,086,685 (-23.05%) |
Filing History |
| 2023-02-07 6:11 pm Sale |
2022-12-30 | 13G | ProQR Therapeutics N.V. PRQR |
GOLDMAN SACHS GROUP INC GS |
9,164 0.000% |
-3,964,486 (-99.77%) |
Filing History |
| 2022-12-23 4:39 pm Purchase |
2022-12-21 | 13G | ProQR Therapeutics N.V. PRQR |
LILLY ELI & CO LLY |
13,371,562 16.600% |
9,381,586 (+235.13%) |
Filing History |
| 2022-05-09 3:31 pm Sale |
2022-04-29 | 13G | ProQR Therapeutics N.V. PRQR |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-4,017,760 (Position Closed) |
Filing History |
| 2022-02-14 08:10 am Purchase |
2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
RTW Investments, LP | 7,027,725 9.900% |
1,939,232 (+38.11%) |
Filing History |
| 2022-02-10 10:51 am Purchase |
2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
ADAGE CAPITAL PARTNERS GP LLC | 4,715,152 6.630% |
165,090 (+3.63%) |
Filing History |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | ProQR Therapeutics N.V. PRQR |
FMR CORP | 4,462,438 6.271% |
4,224,522 (+1775.64%) |
Filing History |
| 2022-02-07 1:57 pm Purchase |
2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
GOLDMAN SACHS GROUP INC GS |
3,973,650 5.600% |
467,286 (+13.33%) |
Filing History |
| 2022-02-04 4:58 pm Purchase |
2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
Stichting Aescap Life Sciences | 4,827,372 6.800% |
1,623,176 (+50.66%) |
Filing History |
| 2022-02-04 09:12 am Purchase |
2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
WELLINGTON MANAGEMENT CO LLP | 4,017,760 5.650% |
561,995 (+16.26%) |
Filing History |
| 2021-09-10 1:03 pm Purchase |
2021-09-03 | 13G | ProQR Therapeutics N.V. PRQR |
LILLY ELI & CO LLY |
3,989,976 5.600% |
3,989,976 (New Position) |
Filing History |
| 2021-04-05 6:26 pm Purchase |
2021-02-01 | 13G | ProQR Therapeutics N.V. PRQR |
RTW Investments, LP | 5,088,493 10.100% |
78,725 (+1.57%) |
Filing History |